These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10411412)

  • 21. Treatment of Microsporum spp. tinea capitis with pulsed oral terbinafine.
    Ungpakorn R; Ayutyanont T; Reangchainam S; Supanya S
    Clin Exp Dermatol; 2004 May; 29(3):300-3. PubMed ID: 15115516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of terbinafine in children.
    Gupta AK; Cooper EA; Lynde CW
    Dermatol Clin; 2003 Jul; 21(3):511-20. PubMed ID: 12956204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Terbinafine: efficacy and tolerability in young children with tinea capitis due to Microsporum canis.
    Silm H; Karelson M
    J Eur Acad Dermatol Venereol; 2002 May; 16(3):228-30. PubMed ID: 12195561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic antifungal therapy for tinea capitis in children.
    González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral terbinafine for tinea capitis due to Microsporum canis in children.
    Baleviciene G; Ceburkovas O; Maciuliene D
    Acta Derm Venereol; 2001; 81(1):61. PubMed ID: 11411922
    [No Abstract]   [Full Text] [Related]  

  • 26. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.
    Fuller LC; Smith CH; Cerio R; Marsden RA; Midgley G; Beard AL; Higgins EM; Hay RJ
    Br J Dermatol; 2001 Feb; 144(2):321-7. PubMed ID: 11251566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of terbinafine in young children treated for tinea capitis.
    Abdel-Rahman SM; Herron J; Fallon-Friedlander S; Hauffe S; Horowitz A; Rivière GJ
    Pediatr Infect Dis J; 2005 Oct; 24(10):886-91. PubMed ID: 16220086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
    Mock M; Monod M; Baudraz-Rosselet F; Panizzon RG
    Dermatology; 1998; 197(4):361-7. PubMed ID: 9873175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of terbinafine treatment of tinea capitis in children varies according to the dermatophyte species.
    Baudraz-Rosselet F; Monod M; Jaccoud S; Frenk E
    Br J Dermatol; 1996 Dec; 135(6):1011-2. PubMed ID: 8977737
    [No Abstract]   [Full Text] [Related]  

  • 30. Systemic antifungal treatment of children with terbinafine.
    Bruckbauer HR; Hofmann H
    Dermatology; 1997; 195(2):134-6. PubMed ID: 9310719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis.
    Haroon TS; Hussain I; Mahmood A; Nagi AH; Ahmad I; Zahid M
    Br J Dermatol; 1992 Feb; 126 Suppl 39():47-50. PubMed ID: 1543673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials.
    Fleece D; Gaughan JP; Aronoff SC
    Pediatrics; 2004 Nov; 114(5):1312-5. PubMed ID: 15520113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis.
    Jahangir M; Hussain I; Ul Hasan M; Haroon TS
    Br J Dermatol; 1998 Oct; 139(4):672-4. PubMed ID: 9892912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of tinea capitis with topical 1% encapsulated terbinafine hydrochloride gel: A pilot study.
    Jerasutus S; Vejjabhinanta V; Prapapan O
    Pediatr Dermatol; 2020 Nov; 37(6):1090-1093. PubMed ID: 32951299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The rising menace of antifungal resistance in dermatophytes among the patients of tinea capitis.
    Zeeshan F; Sabir M; Uddin F
    J Pak Med Assoc; 2023 Jan; 73(1):43-48. PubMed ID: 36842005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic efficacy of terbinafine in the treatment of three children with tinea tonsurans.
    Desgarennes MD; Godoy MR; Palencia AB
    J Am Acad Dermatol; 1996 Jul; 35(1):114-6. PubMed ID: 8682948
    [No Abstract]   [Full Text] [Related]  

  • 37. Tinea capitis caused by Microsporum canis treated with terbinafine.
    Aste N; Pau M
    Mycoses; 2004 Oct; 47(9-10):428-30. PubMed ID: 15504128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. The Study Group.
    Hamm H; Schwinn A; Bräutigam M; Weidinger G
    Br J Dermatol; 1999 Mar; 140(3):480-2. PubMed ID: 10233270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose oral terbinafine in the treatment of pediatric tinea capitis under 2 years old.
    Zhou YB; Chao JJ; Xiao YY; Ma L
    Dermatol Ther; 2022 Apr; 35(4):e15320. PubMed ID: 35038221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tinea capitis and topical Terbinafine cream.
    Redondo-Mateo J; Esquivias-Gómez JI; Carrero-González P
    Int J Dermatol; 2004 May; 43(5):395-6. PubMed ID: 15117379
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.